Director
CuriRx Inc.
Dr. Kaliappanadar Nellaiappan is a director of product development at CuriRx (WWW.curirx.com) and has more than 25 years of experience in the development of new drugs and therapeutic agents. He has led various teams to develop more than 100 dosage formulations throughout his career and continues to head product development and scientific adviser to CuriRx, Inc, He has also been involved in developing novel proprietary drug delivery systems for hydrophobic and hydrophilic molecules, including peptides, Vaccine, LNP, Liposomes and polymer-based oral nanoparticles. He has seven approved patents, several patent applications pending, and more than 50 publications to his name. Dr. Nellaiappan received the Royal Society bursary award from Oxford University.